Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

216
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
216
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

174
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
174
Inflammatory Response01:28

Inflammatory Response

5.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
5.3K
Inflammation01:38

Inflammation

54.7K
Overview
54.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

257
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the bacteria-derived metabolite TMAO as a potential factor contributing to the pathophysiology of delirium in elderly patients with hip fracture.

Brain, behavior, and immunity·2026
Same author

Stable serum peptidoglycan fragment levels do not support leaky gut in the acute phase or at one month following "mild" traumatic brain injury: A preliminary study.

Brain, behavior, & immunity - health·2026
Same author

Spinal fluid antibody profile against bacteria demonstrates intrathecal antibody production in demyelinating diseases.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

The neuroimmune axis and chronic pain disorders.

iScience·2026
Same author

Protease Enzyme Inhibitor Cream for the Prevention of Diaper Dermatitis After Gastrointestinal Surgery in Children: Lessons Learned from a Randomized Controlled Trial.

Children (Basel, Switzerland)·2025
Same author

Single intracerebroventricular TNFR2 agonist injection impacts remyelination in the cuprizone model.

Journal of molecular medicine (Berlin, Germany)·2025

Related Experiment Video

Updated: Aug 29, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Cutting edge technologies in chronic inflammation research.

Jon D Laman1

  • 1Department of Pathology and Medical Biology, University Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.

Experimental Dermatology
|September 5, 2022
PubMed
Summary

State-of-the-art technologies for inflammation research are reviewed, focusing on skin and nervous system diseases. Novel methods like single-cell sequencing and protease inhibitors offer new insights and treatments.

Keywords:
animal modeldiagnostic toolsex vivo modelgut microbiotainflammationnervous systemprotease inhibitorssingle-cell sequencingskinspatial profilingspectral flow cytometry

More Related Videos

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
07:10

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation

Published on: August 16, 2013

20.3K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.0K

Related Experiment Videos

Last Updated: Aug 29, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
07:10

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation

Published on: August 16, 2013

20.3K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.0K

Area of Science:

  • Immunology
  • Dermatology
  • Neuroscience

Background:

  • Inflammation research is crucial for understanding skin and nervous system diseases.
  • Traditional models are being enhanced by innovative approaches.

Purpose of the Study:

  • To review state-of-the-art technologies in inflammation research.
  • To highlight advancements relevant to skin and nervous system diseases.
  • To discuss novel diagnostic and therapeutic strategies.

Main Methods:

  • Review of literature on ex vivo skin explant and animal models.
  • Discussion of spectral flow cytometry and multiplex technology.
  • Exploration of single-cell sequencing and in situ transcriptomics.
  • Presentation of novel antibody-based diagnostic tools.
  • Introduction of protease inhibitors for anti-inflammatory therapy.

Main Results:

  • Ex vivo skin explants and animal models reveal roles of antigen experience and microbiota.
  • Advanced techniques provide granular data on cellular interactions and plasticity.
  • Novel diagnostic tools target specific antibodies.
  • Protease inhibitors show potential as anti-inflammatory agents for skin conditions.

Conclusions:

  • Cutting-edge technologies are revolutionizing inflammation research.
  • These advancements offer new diagnostic and therapeutic avenues for skin and nervous system disorders.
  • Protease inhibitors represent a promising novel strategy for treating skin inflammation.